979 related articles for article (PubMed ID: 1662786)
1. Recovery of pituitary-gonadal function in male and female rats after prolonged administration of a potent antagonist of luteinizing hormone-releasing hormone (SB-75).
Bokser L; Srkalovic G; Szepeshazi K; Schally AV
Neuroendocrinology; 1991 Aug; 54(2):136-45. PubMed ID: 1662786
[TBL] [Abstract][Full Text] [Related]
2. Recovery of pituitary-gonadal function in male rats after long-term suppression induced by a single injection of microcapsules of LH-RH antagonist cetrorelix (SB-75).
Pinski J; Yano T; Szepeshazi K; Groot K; Schally AV
J Androl; 1993; 14(3):164-9. PubMed ID: 8407570
[TBL] [Abstract][Full Text] [Related]
3. Suppression of meiosis of male germ cells by an antagonist of luteinizing hormone-releasing hormone.
Szende B; Redding TW; Schally AV
Proc Natl Acad Sci U S A; 1990 Feb; 87(3):901-3. PubMed ID: 2405399
[TBL] [Abstract][Full Text] [Related]
4. Antifertility effects of a potent LH-RH antagonist in male and female rats.
Debeljuk L; Schally AV
Int J Fertil; 1986; 31(4):284-92. PubMed ID: 2878898
[TBL] [Abstract][Full Text] [Related]
5. Effect of microcapsules of luteinizing hormone-releasing hormone antagonist SB-75 and somatostatin analog RC-160 on endocrine status and tumor growth in the Dunning R-3327H rat prostate cancer model.
Yano T; Pinski J; Szepeshazi K; Milovanovic SR; Groot K; Schally AV
Prostate; 1992; 20(4):297-310. PubMed ID: 1351672
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the pituitary-gonadal axis in nude male mice by continuous administration of LHRH agonists and antagonists.
Redding TW; Schally AV
J Endocrinol; 1990 Aug; 126(2):309-15. PubMed ID: 2144873
[TBL] [Abstract][Full Text] [Related]
7. Sustained release formulations of luteinizing hormone-releasing hormone antagonist SB-75 inhibit proliferation and enhance apoptotic cell death of human prostate carcinoma (PC-82) in male nude mice.
Redding TW; Schally AV; Radulovic S; Milovanovic S; Szepeshazi K; Isaacs JT
Cancer Res; 1992 May; 52(9):2538-44. PubMed ID: 1568223
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of analogs of luteinizing hormone-releasing hormone against chemotherapy-induced testicular damage in rats.
Karashima T; Zalatnai A; Schally AV
Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2329-33. PubMed ID: 2965391
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of a highly potent antagonist of LH releasing hormone (SB-75) on the pituitary gonadal axis in the intact and castrated rat.
Ayalon D; Farhi Y; Comaru-Schally AM; Schally AV; Eckstein N; Vagman I; Limor R
Neuroendocrinology; 1993 Aug; 58(2):153-9. PubMed ID: 8264861
[TBL] [Abstract][Full Text] [Related]
10. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M
J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of analogs of luteinizing hormone-releasing hormone against x-radiation-induced testicular damage in rats.
Schally AV; Paz-Bouza JI; Schlosser JV; Karashima T; Debeljuk L; Gandle B; Sampson M
Proc Natl Acad Sci U S A; 1987 Feb; 84(3):851-5. PubMed ID: 2949328
[TBL] [Abstract][Full Text] [Related]
12. Suppression of pituitary-testis function in rats treated neonatally with a gonadotrophin-releasing hormone agonist and antagonist: acute and long-term effects.
Kolho KL; Huhtaniemi I
J Endocrinol; 1989 Oct; 123(1):83-91. PubMed ID: 2509621
[TBL] [Abstract][Full Text] [Related]
13. Pituitary-testis function in rats treated neonatally with a gonadotrophin-releasing hormone agonist: short- and long-term effects.
Garnelo P; Pinilla L; Gaytan F; Aguilar E
J Endocrinol; 1992 Aug; 134(2):269-77. PubMed ID: 1402537
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of pituitary receptors for luteinizing hormone-releasing hormone (LH-RH) in rats by LH-RH antagonist Cetrorelix.
Halmos G; Schally AV; Pinski J; Vadillo-Buenfil M; Groot K
Proc Natl Acad Sci U S A; 1996 Mar; 93(6):2398-402. PubMed ID: 8637885
[TBL] [Abstract][Full Text] [Related]
15. Regression of nitrosamine-induced pancreatic cancers in hamsters treated with luteinizing hormone-releasing hormone antagonists or agonists.
Szende B; Srkalovic G; Groot K; Lapis K; Schally AV
Cancer Res; 1990 Jun; 50(12):3716-21. PubMed ID: 2160323
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of growth of experimental prostate cancer with sustained delivery systems (microcapsules and microgranules) of the luteinizing hormone-releasing hormone antagonist SB-75.
Korkut E; Bokser L; Comaru-Schally AM; Groot K; Schally AV
Proc Natl Acad Sci U S A; 1991 Feb; 88(3):844-8. PubMed ID: 1992476
[TBL] [Abstract][Full Text] [Related]
17. Gonadotropin gene expression and secretion in gonadotropin-releasing hormone antagonist-treated male rats: effect of sex steroid replacement.
Perheentupa A; Huhtaniemi I
Endocrinology; 1990 Jun; 126(6):3204-9. PubMed ID: 1693570
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of pituitary-gonadal function in male rats by a potent GnRH antagonist.
Puente M; Catt KJ
J Steroid Biochem; 1986 Dec; 25(6):917-25. PubMed ID: 3025519
[TBL] [Abstract][Full Text] [Related]
19. Acute and chronic effects of a gonadotrophin-releasing hormone antagonist on pituitary and testicular function in monkeys.
Bint Akhtar F; Weinbauer GF; Nieschlag E
J Endocrinol; 1985 Mar; 104(3):345-54. PubMed ID: 3882872
[TBL] [Abstract][Full Text] [Related]
20. Prostate carcinoma tumor size in rats decreases after administration of antagonists of luteinizing hormone-releasing hormone.
Redding TW; Coy DH; Schally AV
Proc Natl Acad Sci U S A; 1982 Feb; 79(4):1273-6. PubMed ID: 6803239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
